Good Signal Detection Practices: Evidence from IMI PROTECT
Open Access
- 7 March 2016
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 39 (6) , 469-490
Abstract
Over a period of 5 years, the Innovative Medicines Initiative PROTECT (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium) project has addressed key research questions relevant to the science of safety signal detection. The results of studies conducted into quantitative signal detection in spontaneous reporting, clinical trial and electronic health records databases are summarised and 39 recommendations have been formulated, many based on comparative analyses across a range of databases (e.g. regulatory, pharmaceutical company). The recommendations point to pragmatic steps that those working in the pharmacovigilance community can take to improve signal detection practices, whether in a national or international agency or in a pharmaceutical company setting. PROTECT has also pointed to areas of potentially fruitful future research and some areas where further effort is likely to yield less.Keywords
Funding Information
- Innovative Medicine Initiative Joint Undertaking (115004)
This publication has 72 references indexed in Scilit:
- Vaccine-Based Subgroup Analysis in VigiBaseDrug Safety, 2012
- Terminological Challenges in Safety SurveillanceDrug Safety, 2012
- Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARDPharmacoepidemiology and Drug Safety, 2010
- A potential competition bias in the detection of safety signals from spontaneous reporting databasesPharmacoepidemiology and Drug Safety, 2010
- A Decade of Data Mining and Still CountingDrug Safety, 2010
- Validation of Statistical Signal Detection Procedures in EudraVigilance Post-Authorization DataDrug Safety, 2010
- Adaptation of Bayesian Data Mining Algorithms to Longitudinal Claims DataMedical Care, 2008
- Detecting signals of drug–drug interactions in a spontaneous reports databaseBritish Journal of Clinical Pharmacology, 2007
- ???Extreme Duplication??? in the US FDA Adverse Events Reporting System DatabaseDrug Safety, 2007
- Appraisal of the MedDRA Conceptual Structure for Describing and Grouping Adverse Drug ReactionsDrug Safety, 2005